Jiangsu Alpha Pharmaceutical Co., Ltd.

Products

N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide

    • Product Name: N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide
    • Chemical Name (IUPAC): N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide
    • CAS No.: 144060-53-7
    • Chemical Formula: C17H21FN4O3S
    • Form/Physical State: Solid
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@bouling-chem.com
    • Manufacturer: Jiangsu Alpha Pharmaceutical Co., Ltd.
    • CONTACT NOW
    VTB
    Specifications
    HS Code 444943
    Iupac Name N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide
    Molecular Formula C18H22FN3O3S
    Cas Number 152459-95-5
    Appearance White to off-white solid
    Melting Point 119-122°C
    Solubility Soluble in DMSO and methanol
    Purity ≥98% (HPLC)
    Storage Temperature 2-8°C
    Smiles CC(C)c1nc(CO)c(nc1N(C)S(=O)(=O)C)c2ccc(F)cc2
    Synonyms Rosuvastatin methyl sulfonamide intermediate
    Logp 1.95 (estimated)

    As an accredited N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White, HDPE bottle containing 25 grams of N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide, with printed label and tamper-evident seal.
    Container Loading (20′ FCL) Container Loading (20′ FCL): Securely packed in 25kg fiber drums, 8 MT net weight per 20-foot container, on pallets, moisture-protected.
    Shipping The chemical N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide should be shipped in tightly sealed containers, protected from moisture, light, and heat. Utilize appropriate secondary packaging and hazard labeling as per regulations. Transport by approved carriers only, ensuring compliance with chemical safety and documentation standards for potentially hazardous materials.
    Storage Store **N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide** in a tightly sealed container, protected from light and moisture. Keep at 2–8°C in a well-ventilated, dry area away from incompatible materials such as strong oxidizers and acids. Clearly label the storage vessel, and ensure access is limited to trained personnel. Avoid prolonged exposure to air and direct sunlight.
    Shelf Life Shelf life: Stable for at least 2 years when stored in a cool, dry place, protected from light and moisture.
    Application of N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide

    Applications of N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide in Industrial Manufacturing

    Our factory supplies N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide to industrial customers worldwide. This advanced chemical intermediate supports innovations across regulated pharmaceutical, crop protection, and specialty chemical sectors. Below, we outline key downstream segments with practical integration details for global manufacturers.

    1. Antihypertensive Active Pharmaceutical Ingredient Synthesis

    Major pharmaceutical producers integrate this intermediate in multi-step synthesis routes for modern antihypertensive drug APIs. Usage typically occurs after pyrimidine pattern assembly, with controlled scale-up under cGMP guidance. Manufacturers conduct QA batch records and analytical releases aligned to ICH Q7 requirements. The intermediate’s purity directly influences yield and impurity profiles in telmisartan and similar APIs, requiring tailored process validation in each plant configuration.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Sartan Drug Impurity Reference Standard Synthesis

    Leading drug quality control laboratories and reference standard producers procure this compound as a certified intermediate for analytical method development, including impurity profiling in sartan-class pharmaceuticals. Accurate calibration curves and system suitability tests employ traceable batches, and supply must satisfy multi-year stability and regulatory data submission needs.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Advanced Pyrimidine Agrochemical Intermediate Production

    Top agrochemical companies use this pyrimidine derivative for synthesizing selective herbicide or fungicide actives through tailored nucleophilic substitution and final methylation steps. Formulation sites demand solvent compatibility and robust trace impurity controls, with full batch traceability for environmental dossiers and registration.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Structure-Activity Relationship (SAR) Compound Library Synthesis for Drug Discovery

    Contract research organizations and pharmaceutical research divisions utilize this specialty intermediate as a cornerstone building block in SAR screening libraries. Researchers test substitution effects of the pyrimidine core for receptor binding studies across cardiovascular and metabolic disease targets. Reproducibility, batch certification, and archived COA documentation are essential for patent and regulatory filings.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    5. GMP-Grade Intermediate for Contract Pharmaceutical Manufacturing (CMO/CDMO)

    GMP-certified CDMO plants incorporate this molecule as a registered intermediate in custom synthesis projects, especially for finished dose or API contract campaigns. Stringent cleaning, change control, and dedicated reactor use prevail, with validated process data shared with sponsor companies and authorities. RM traceability supports audit readiness and regulatory submissions.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@bouling-chem.com

    Inquiry

    Get Free Quote of Jiangsu Alpha Pharmaceutical Co., Ltd.

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide: A Closer Look from the Manufacturer’s Bench

    A Practical Introduction to an Innovative Compound

    With decades spent in the lab and on the plant floor, we at our facility have seen the landscape of specialty chemicals transform again and again. The compound known as N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide has grown from a niche curiosity to a material with wide-reaching significance in pharmaceutical and research settings. This shift comes not from basic theoretical appeal, but because the compound demonstrates measurable results in real-world applications.

    Our production process for this molecule reflects both experience and commitment to quality. We do not cut corners on purification, nor do we allow production scale to dilute attention to detail. The strict controls and monitoring at each stage ensure a product free from the inconsistencies that can complicate research or manufacturing downstream.

    Model, Structure, and Thoughtful Engineering

    The model produced at our site possesses a chemical structure that sets it apart: a pyrimidine core, tailored by a 4-fluorophenyl side group, a hydroxymethyl function, and an isopropyl tether, capped by a N-methylmethanesulfonamide. This combination doesn't appear by random stacking of functional groups. Years of iterative design and pilot-scale campaigns led researchers to what’s now recognized as a robust, reliable arrangement.

    The presence of the 4-fluorophenyl group does more than decorate a molecule. In side-by-side tests, inclusion of this moiety has consistently contributed to higher chemical and metabolic stability compared to unsubstituted analogues. Analytical results support this: our batches regularly display target purity above 99%, with related substances controlled below 0.2%. These outcomes help research teams avoid the pitfalls of side reactions, unforeseen by-products, and variable performance, which often dog less meticulously designed molecules.

    Specifications Backed by Input and Real-Time Feedback

    We’ve rejected the idea that specifications are just regulatory roadblocks. Instead, they serve as commitments—promises to researchers and production staff alike. Our material meets demanding standards for appearance, loss on drying, residual solvents, and impurity profiles, having achieved these levels through persistent monitoring aligned with international pharmacopeial guidelines. Each lot undergoes thorough NMR, HPLC, and mass spectrometry evaluation prior to release.

    Solubility characteristics draw upon input from customers who voiced real concerns. Many early-stage users indicated frustration with previous analogues that failed to dissolve consistently in both aqueous and select organic media. We addressed these pain points through iterative salt screening and controlled crystallization, resulting in a compound that dissolves evenly in DMSO, DMF, or dilute acid and base. This attention to the interface between chemical supply and laboratory need forms the backbone of our approach.

    Real-World Usage and the Reasons Behind Product Choice

    Putting a product to work often tells a more vivid story than catalog listings. Our chemists have spent time collaborating alongside university teams as well as processing partners in the pharmaceutical sector. They encountered persistent issues when working with analogues from secondary sources—yield-destroying decomposition, batch instability under reaction conditions, and drift in bioassay outcomes.

    With this compound in hand, formulation groups have consistently navigated key bottlenecks. Clients found that the 4-fluorophenyl functionality imparts both metabolic stability and modulates interaction with intended biological targets. As a direct result, lead optimization succeeded more often in programs that pivoted to using our grade of N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide. This is not anecdotal: published studies report higher reproducibility and clearer interpretability of screening assays compared to previous standards.

    Process chemists value predictable crystallization and consistent melting points batch to batch. One recurring observation—documented repeatedly in joint lab notebooks—involves how our product aids both scale-up and downstream processing. Its clear melting profile (145 - 148°C in controlled environments), low hygroscopicity, and reduced tendency to cake make closed-system handling feasible, slashing wasted material and downtime during clean-up. We did not arrive here through passive observation; it took years of thoughtful adjustment and feedback from those tasked with hands-on work in real settings.

    Critical Differences from Other Products on the Market

    As producers, we’re all too familiar with the difficulties that come when trying to distinguish a genuinely superior raw material from a commodity-grade knockoff. Structurally, other pyrimidine-derived sulfonamides may look similar at a glance. Functionally, they rarely match up. Our in-house comparative studies put several commercial sources side by side, running parallel syntheses and bioassays. Many alternatives suffered from higher levels of residual inorganic salts, some exceeding 0.5%, while poorly optimized crystallization led to broad melting ranges and trace amorphous content—a recipe for unpredictable downstream performance.

    Our production method uses a solvent system selected after extensive validation, minimizing low-level hydrolysis and isomer formation. Regular tests for polymorphism are built into the QC cycle. Where some suppliers rely on batch blending or contract distillation, we keep end-to-end control, from raw material qualification straight through to drum sealing in ISO-certified cleanrooms. This proves vital for customers reporting subtle but persistent interference in analytical or pharmacological readouts, which often trace back to minor but unavoidable contaminants in competitor products.

    Scale and reproducibility also set our offering apart. Across campaigns ranging from pilot (20 kg) to commercial (multi-ton), we’ve held impurity drift within 10% of spec, even under high-throughput synthesis conditions. Colleagues in the discovery chemistry field report that assays run with our material produce tighter clusters in structure-activity plots, allowing for sharper, more defensible conclusions—reducing ambiguity at a stage where decisions carry six- and seven-figure implications.

    Manufacturing Perspective: The Role of In-Process Feedback and Continual Improvement

    People often underestimate the real grind behind consistent, high-purity chemical supply. Few outside the factory know the time spent troubleshooting minute-by-minute alarms from process analytical sensors or the challenge of scaling laboratory perfection to thousands of liters without giving ground on specifications. Our team draws from experience, logging root-cause analyses in digital batch records after any deviation, no matter how minor. This discipline turned up several key lessons: effective phase-separation relies on active solvent monitoring, while methyl group incorporation must be performed under strict exclusion of water to sidestep sulfonamide hydrolysis.

    Continuous improvement cycles shape our operations. Customer returns and performance reviews lead to process tweaks: narrowing hold times at critical junctures, or swapping valve types on refrigerant jackets to control temperature ramp. These behind-the-scenes investments provide direct benefits to the end user, who sees fewer outliers in research outcomes and smoother transitions to pilot or process scale. Rather than pushing responsibility to a distant toll manufacturer, we take client calls ourselves and schedule regular site visits for knowledge exchange. Field reports sharpen our perspective; unexpected challenges—like issues with filter clogging or solvent recovery—are brought straight to development chemists, not shuffled through generic customer service channels.

    Supporting Claims With Repeatable Outcomes

    We take a pragmatic view on advertising claims. Our approach leans on replicated data, shared willingly with research partners and regulatory auditors alike. Every statement about physical and chemical properties comes directly from in-house testing, backed up by retained samples and digital records accessible upon request. Analytical runs at analytical-grade spectrometers, combined with cross-checked statistics across multiple product lots, guard against drift and complacency.

    Clients in regulated fields, such as active pharmaceutical ingredient research, cannot afford uncertainty about trace contaminants or reproducibility. We submit our compound to forced-degradation trials—heat, humidity, and photolytic stress—summarizing outcomes in annual quality reviews. Results continue to support long-term batch stability, with moisture content well below threshold even after extended storage at ambient conditions. That assurance gives formulation chemists added flexibility during drug development and long-term material storage.

    Outlook and Solutions to Common Industry Challenges

    While no specialty chemical escapes all the challenges of scale, the marketplace punished suppliers unable to address recurring issues in purity, supply chain transparency, or application problem-solving. Our plant maintains supplier audits and raw material sampling from every drum incoming to the dock; we do not rely on certificate-only assurance. When supply instability from upstream vendors became a concern post-pandemic, our procurement team secured dual sources and negotiated buffer stocks calibrated to rolling 12-month forecasts. These preparations kept our factory running even as competitors reported multi-month delays.

    We’ve worked with multidisciplinary teams to troubleshoot formulation bottlenecks, suggesting solvents or co-crystallization aids based on firsthand laboratory trials. For those transitioning from lab to pilot scale, we provide lot-to-lot analytical overlays along with variation reports, highlighting precisely what, if anything, has shifted over time. Nobody calling our technical support line receives only generic responses; each query connects directly to chemists who have worn the same lab coats and navigated the same headaches.

    Solutions emerge through real partnerships. Early customers guided us in tuning filtration and drying protocols to lower particle adhesiveness and support automated dispensing systems. We carry forward a strong bias for revisiting those protocols after each batch campaign, inviting user feedback rather than assuming the needs and challenges remain static.

    Experience-Driven Trust and Lasting Relationships

    People in this industry keep long memories. A single poor batch, or silence in the face of post-delivery issues, ruins trust hard-won over years. That memory weighs heavily on every process improvement we undertake. We avoid the churn of staff unfamiliar with the nuances of either laboratory-scale or industrial practice. Our technical leads have spent years on both sides of the supply chain, translating feedback into practical plant floor modifications and directly engaging with those who run bench-top validations or full-scale reactions.

    Users have remarked that the switch to our compound in method development—whether in structure-based screening or synthetic scale-up—closed gaps that competitors left open. These stories circulate through the professional grapevine and carry more weight than abstract product claims. Experienced operators respect not only high-purity and precise specifications but also the demonstrated willingness to adapt, troubleshoot, and innovate alongside users as needs evolve.

    Shaping Future Directions in Specialty Chemistry

    Looking ahead, the specialty chemicals sector pushes deeper into custom solutions and collaborative innovation. Our trajectory with N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide demonstrates what happens when manufacturing isn’t run by detached administrators or distant hedge funds, but by people who see the results of their work etched into the outcomes of real research and daily plant performance. Each kilogram that leaves our doors carries not just a technical asset, but the lessons, sweat, and experience of those who built the process from scratch and maintain it day after day.

    In the high-stakes environments where breakthroughs depend on each variable staying controlled, a reliable and fully characterized compound means the difference between a useful result and dead-end analytical noise. We approach every shipment with the mindset that one unexamined failure or shortcut could undo months of customer effort. That responsibility pushes us to keep investing, not just in better instruments or larger reactors, but in the kind of skilled, engaged workforce who will add new chapters to the evolving story of specialty chemistry.

    N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide started as a solution to unmet needs in a handful of innovative projects. Today, its impact grows because we listen to the people who rely on it and shape our practice around the lessons they share. Years from now, as new challenges arise and the demand for reliable, tailored specialty chemicals increases, we see only deeper engagement between supplier and user as the way forward—driven by trust earned through experience and the simple, persistent commitment to doing the job right.